✦ LIBER ✦

Exploring the Use of Pharmacological Chaperone AT3375 Alone and in Combination with Recombinant human ß-Glucosidase for Gaucher Disease

✍ Scribed by Richie Khanna; Lee Pellegrino; Rebecca Soska; Yi Lun; Jessie Feng; Michelle Frascella; Brian E. Ranes; Darlene Guillen; Anadina Garcia; John J. Flanagan; David J. Lockhart; Sean W. Clark; Kenneth J. Valenzano

Book ID: 116989579
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 56 KB
Volume: 105
Category: Article
ISSN: 1096-7192
DOI: 10.1016/j.ymgme.2011.11.093

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Exploring the use of a co-formulated pha

Exploring the use of a co-formulated pharmacological chaperone AT2220 with recombinant human acid alpha-glucosidase for Pompe disease

✍ Khanna, Richie; Xu, Su; Lun, Yi; Soska, Rebecca; Feng, Jessie; Frascella, Michel 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Subcutaneous administration of recombina

Subcutaneous administration of recombinant human acid α-glucosidase co-formulated with the pharmacological chaperone AT2220 leads to lysosomal uptake of rhGAA and glycogen reduction in disease-relevant tissues of mice with Pompe disease

✍ Lun, Yi; Pellegrino, Lee; Xu, Su; Feng, Jessie; Soska, Rebecca; Frascella, Miche 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 48 KB

P.17.8 The co-formulation of pharmacolog

P.17.8 The co-formulation of pharmacological chaperone AT2220 with recombinant human acid alpha-glucosidase improves enzyme uptake and glycogen reduction in a mouse model of Pompe disease

✍ Khanna, R.; Xu, S.; Pellegrino, L.; Lun, Y.; Soska, R.; Feng, J.; Frascella, M.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 57 KB